These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2983121)

  • 1. A monoclonal antibody that neutralizes poliovirus by cross-linking virions.
    Thomas AA; Brioen P; Boeyé A
    J Virol; 1985 Apr; 54(1):7-13. PubMed ID: 2983121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between poliovirus neutralization and aggregation.
    Thomas AA; Vrijsen R; Boeyé A
    J Virol; 1986 Aug; 59(2):479-85. PubMed ID: 3016307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hit-and-run neutralization of poliovirus.
    Brioen P; Rombaut B; Boeyé A
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2495-9. PubMed ID: 2997379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of poliovirus by antibody-mediated polymerization.
    Brioen P; Dekegel D; Boeyé A
    Virology; 1983 Jun; 127(2):463-8. PubMed ID: 6306919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion.
    Wetz K; Willingmann P; Zeichhardt H; Habermehl KO
    Arch Virol; 1986; 91(3-4):207-20. PubMed ID: 3022677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization.
    Emini EA; Ostapchuk P; Wimmer E
    J Virol; 1983 Nov; 48(2):547-50. PubMed ID: 6194315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.
    Icenogle J; Shiwen H; Duke G; Gilbert S; Rueckert R; Anderegg J
    Virology; 1983 Jun; 127(2):412-25. PubMed ID: 6306918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.
    Emini EA; Jameson BA; Lewis AJ; Larsen GR; Wimmer E
    J Virol; 1982 Sep; 43(3):997-1005. PubMed ID: 6183443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliovirus neutralization and the percentage law. Brief report.
    Brioen P; Boeyé A
    Arch Virol; 1985; 83(1-2):105-11. PubMed ID: 2982345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
    Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
    J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Schild GC
    Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic N to H conversion of poliovirus by a monoclonal antibody at low ionic strength.
    Delaet I; Vrijsen R; Boeyé A
    Virology; 1992 May; 188(1):93-101. PubMed ID: 1314469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope.
    Wien MW; Filman DJ; Stura EA; Guillot S; Delpeyroux F; Crainic R; Hogle JM
    Nat Struct Biol; 1995 Mar; 2(3):232-43. PubMed ID: 7539711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
    Ruggeri FM; Greenberg HB
    J Virol; 1991 May; 65(5):2211-9. PubMed ID: 1850007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intertypic cross-neutralization of polioviruses by human monoclonal antibodies.
    Uhlig H; Dernick R
    Virology; 1988 Mar; 163(1):214-7. PubMed ID: 2831657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions.
    Blondel B; Akacem O; Crainic R; Couillin P; Horodniceanu F
    Virology; 1983 Apr; 126(2):707-10. PubMed ID: 6190311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of quantitative correlation between the neutralization of poliovirus and the antibody-mediated pI shift of the virions.
    Brioen P; Thomas AA; Boeyé A
    J Gen Virol; 1985 Mar; 66 ( Pt 3)():609-13. PubMed ID: 2983003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
    Fiore L; Ridolfi B; Genovese D; Buttinelli G; Lucioli S; Lahm A; Ruggeri FM
    J Virol; 1997 Sep; 71(9):6905-12. PubMed ID: 9261417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
    Ludert JE; Ruiz MC; Hidalgo C; Liprandi F
    J Virol; 2002 Jul; 76(13):6643-51. PubMed ID: 12050377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.
    Taniguchi K; Urasawa S
    Arch Virol; 1987; 92(1-2):27-40. PubMed ID: 2432854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.